India’s elite bridal market is increasingly offering the O‑Shot — a platelet‑rich plasma (PRP) injection marketed as an “orgasm shot” to boost libido, sensitivity and lubrication ahead of the honeymoon — but gynaecologists warn the treatment remains largely experimental and unproven. Clinics promise stronger orgasms and better sexual pleasure by injecting a patient’s own blood‑derived platelets into vaginal and clitoral tissue, yet leading doctors say robust evidence of benefit is lacking and regulatory approval is absent.
The O‑Shot procedure involves drawing a patient’s blood, centrifuging it to concentrate platelets, then injecting the platelet‑rich plasma into predetermined spots in the vaginal wall and clitoral area. Proponents argue higher local platelet counts stimulate tissue regeneration, improve blood flow and increase sensation. As Dr Tripti Raheja, director of obstetrics and gynaecology at CK Birla Hospital, Delhi, explains, “The O‑Shot…involves the injection of platelet‑rich plasma, extracted from a patient’s blood, into vaginal tissues for the purpose of improving sexual performance by increasing blood flow and sensitivity to the vagina.”
Claims of effectiveness rest largely on small or preliminary studies and patient reports. A pilot study from a Turkish clinic reported subjective improvements in libido and orgasmic function, but a 2023 systematic review concluded there is “no clear evidence” that PRP injections improve female sexual dysfunction. Dr Raheja cautions that “no well‑designed studies have been performed to establish the effectiveness of the O‑Shot,” and Dr Juhee Jain, director of obstetrics and gynaecology at Madhukar Rainbow Children’s Hospital, says the procedure is “not evidence‑based on current standards of care.” Some clinicians also note that reported gains may reflect placebo effects.
Popularity appears driven by marketing that frames the O‑Shot as “natural” and low‑risk because it uses the patient’s own blood. Doctors counter that long‑term effects are unknown and the treatment is not approved by bodies such as the US Food and Drug Administration for sexual dysfunction. Risks include pain, swelling, bruising, infection, nerve sensitivity and temporary altered sensations; rare reports cite tissue damage or scarring. As Dr Raheja says, “Due to the lack of studies, the long‑term effects of the treatment are not known.”
Physicians advise caution. Dr Jain calls the therapy experimental, urging anyone considering it to consult a qualified physician, discuss candidacy and have realistic expectations; she adds that in her experience patients undergoing the procedure are rare. While PRP may be explored as an add‑on for specific medical problems such as vaginal dryness or stress incontinence, doctors stress the O‑Shot is not a quick cosmetic fix for honeymoon performance or a substitute for addressing hormonal, psychological or relationship causes of sexual dysfunction.
Original Source: https://timesofindia.indiatimes.com/india/orgasm-shots-the-controversial-happy-ending-being-marketed-to-brides/articleshow/130367470.cms
Category:
Tags:
Publish Date: 2026-04-19 18:43:00
